Previous close | 69.56 |
Open | 69.46 |
Bid | 70.04 x 1100 |
Ask | 70.08 x 800 |
Day's range | 69.03 - 70.18 |
52-week range | 63.92 - 88.78 |
Volume | |
Avg. volume | 789,817 |
Market cap | 34.34B |
Beta (5Y monthly) | 0.66 |
PE ratio (TTM) | 75.34 |
EPS (TTM) | 0.93 |
Earnings date | N/A |
Forward dividend & yield | 0.21 (0.27%) |
Ex-dividend date | 03 May 2022 |
1y target est | 85.83 |
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
GENEVA, August 09, 2022--Alcon Reports Second Quarter 2022 Results
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.